Philadelphia Trust Company’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-17,807
| Closed | -$1.05M | – | 253 |
|
|
2024
Q2 | $1.05M | Sell |
17,807
-99,477
| -85% | -$6.22M | 0.08% | 113 |
|
|
2024
Q1 | $9.36M | Sell |
117,284
-339
| -0.3% | -$25.9K | 0.75% | 40 |
|
|
2023
Q4 | $9.29M | Buy |
117,623
+6,739
| +6% | +$480K | 0.87% | 31 |
|
|
2023
Q3 | $7.74M | Buy |
110,884
+4,643
| +4% | +$329K | 0.8% | 39 |
|
|
2023
Q2 | $7.34M | Buy |
106,241
+2,666
| +3% | +$190K | 0.7% | 44 |
|
|
2023
Q1 | $7.7M | Sell |
103,575
-131,446
| -56% | -$11M | 0.78% | 33 |
|
|
2022
Q4 | $21.9M | Sell |
235,021
-39,698
| -14% | -$3.83M | 2.35% | 11 |
|
|
2022
Q3 | $26.2M | Sell |
274,719
-6,962
| -2% | -$689K | 2.96% | 9 |
|
|
2022
Q2 | $26.1M | Sell |
281,681
-17,061
| -6% | -$1.67M | 2.68% | 9 |
|
|
2022
Q1 | $30.2M | Sell |
298,742
-3,613
| -1% | -$380K | 2.39% | 11 |
|
|
2021
Q4 | $31.2M | Sell |
302,355
-50,457
| -14% | -$4.66M | 2.26% | 12 |
|
|
2021
Q3 | $29.9M | Buy |
352,812
+74,472
| +27% | +$6.24M | 2.21% | 14 |
|
|
2021
Q2 | $23.2M | Sell |
278,340
-1,726
| -0.6% | -$141K | 1.6% | 19 |
|
|
2021
Q1 | $21.1M | Buy |
280,066
+5,110
| +2% | +$372K | 1.62% | 18 |
|
|
2020
Q4 | $18.8M | Sell |
274,956
-29,846
| -10% | -$1.94M | 1.53% | 19 |
|
|
2020
Q3 | $17.8M | Sell |
304,802
-52,323
| -15% | -$3.26M | 1.72% | 19 |
|
|
2020
Q2 | $23.2M | Sell |
357,125
-33,612
| -9% | -$2.12M | 2.44% | 11 |
|
|
2020
Q1 | $23.2M | Buy |
390,737
+78,691
| +25% | +$5.25M | 2.92% | 10 |
|
|
2019
Q4 | $23.2M | Sell |
312,046
-6,775
| -2% | -$476K | 1.99% | 13 |
|
|
2019
Q3 | $20.1M | Buy |
318,821
+5,783
| +2% | +$343K | 1.87% | 14 |
|
|
2019
Q2 | $17.1M | Sell |
313,038
-19,654
| -6% | -$1.06M | 1.5% | 20 |
|
|
2019
Q1 | $17.9M | Buy |
332,692
+87,649
| +36% | +$5.41M | 1.58% | 20 |
|
|
2018
Q4 | $16.1M | Buy |
245,043
+211,631
| +633% | +$15.8M | 1.71% | 17 |
|
|
2018
Q3 | $2.63M | Buy |
33,412
+355
| +1% | +$25.4K | 0.22% | 78 |
|
|
2018
Q2 | $2.13M | Buy |
33,057
+865
| +3% | +$57K | 0.19% | 85 |
|
|
2018
Q1 | $2M | Sell |
32,192
-1,652
| -5% | -$119K | 0.17% | 90 |
|
|
2017
Q4 | $2.45M | Sell |
33,844
-225,541
| -87% | -$16.4M | 0.19% | 81 |
|
|
2017
Q3 | $21.1M | Sell |
259,385
-64,249
| -20% | -$5.08M | 1.73% | 20 |
|
|
2017
Q2 | $26M | Sell |
323,634
-17,017
| -5% | -$1.34M | 2.21% | 11 |
|
|
2017
Q1 | $26.7M | Buy |
340,651
+18,642
| +6% | +$1.49M | 2.2% | 9 |
|
|
2016
Q4 | $25.4M | Sell |
322,009
-23,764
| -7% | -$1.92M | 2.03% | 11 |
|
|
2016
Q3 | $30.8M | Buy |
345,773
+9,118
| +3% | +$861K | 2.66% | 6 |
|
|
2016
Q2 | $32.2M | Buy |
336,655
+1,626
| +0.5% | +$162K | 2.79% | 6 |
|
|
2016
Q1 | $34.8M | Buy |
335,029
+58,274
| +21% | +$5.67M | 2.98% | 5 |
|
|
2015
Q4 | $26.7M | Buy |
276,755
+56,262
| +26% | +$5.51M | 2.24% | 10 |
|
|
2015
Q3 | $21.3M | Buy |
+220,493
| New | +$23.2M | 1.92% | 17 |
|
Other funds holding CVS
Philadelphia Trust Company's CVS Position: Q3 2024 in Review
Philadelphia Trust Company sold out of CVS Health (CVS) in Q3 2024, closing a stake of 17,807 shares — an estimated $1.05M sold.
Philadelphia Trust Company first reported a position in CVS in Q3 2015 and held it in 36 quarters. The position peaked at $34.8M in Q1 2016. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.
- Philadelphia Trust Company reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
- Philadelphia Trust Company sold 17,807 CVS Health shares in Q3 2024, an estimated $1.05M.
- Philadelphia Trust Company first reported a position in CVS Health in Q3 2015 and held it in 36 quarters.
- Philadelphia Trust Company's CVS Health position peaked at $34.8M in Q1 2016.
- 1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.
Based on Philadelphia Trust Company's 13F filing for Q3 2024, filed 13 Nov 2024.